Siemens, Roche, Beckman Coulter Battle for Share of $8.5 Billion In Vitro Diagnostic Market with Point-of-Care and Immunoassay Products

VANCOUVER, June 7 /PRNewswire-FirstCall/ - According to a new report series by iData Research (www.idataresearch.net), the leading global authority in medical device and pharmaceutical market research, the U.S. in-vitro diagnostic market, including immunochemistry, molecular diagnostics, point-of-care testing, blood-donor screening, hematology and hemostasis is valued at over $8.5 billion. Growth will be fueled by sales of new Food and Drug Administration (FDA) approved assays for diseases and conditions that traditionally relied on other diagnostic methods.

"Immunoassay and molecular diagnostic sales growth will drive the overall in-vitro diagnostic market to almost $10 billion by 2017," says Dr. Kamran Zamanian, CEO of iData. "In 2010, the molecular diagnostics market experienced a spike in growth due to the introduction of new FDA approved assays for the Herpes simplex virus (HSV) while immunoassay testing volumes for cancer markers grew by almost 8%."

The report states that laboratories in the U.S. are converting from manual to automated testing methods for immunoassay, chemistry and urinalysis testing. This is encouraging sales of new, premium priced analyzers with more automated and integrated features. In addition, the reproductive and fertility assay market will experience strong growth in test volumes as the average maternal age in the U.S. increases.

Furthermore, Roche Diagnostics, Abbott Laboratories, Siemens Healthcare, Beckman Coulter and Radiometer were the top companies in the U.S. point-of-care testing market, which is expected to approach $1.5 billion in annual sales by 2017. Point-of-care testing can occur at the bedside or in the physician office lab setting, allowing physicians to receive and deliver results, and recommend treatment, in a shorter period of time than traditional laboratory testing. Favorable reimbursement for physicians and the demand for continuous testing from chronic conditions such as diabetes is driving this market.

iData's U.S. and European report series on "The Markets for In-Vitro Diagnostics 2011" includes the latest data, market-analyses and competitor profiles for over 39 segments.

For more information, register free on iData's website at: http://www.idataresearch.net/idata/registration.php

About iData Research

iData Research (www.idataresearch.net/idata/discoveridata.php) is an international market research and consulting group focused on providing market intelligence for medical device and pharmaceutical companies. iData covers research in: diagnostics, cardiovascular, orthopedics, dental, and more.

CONTACT: Drew Gutschmidt, iData Research, [email protected]

SOURCE iData Research Inc.